Product Details for ANDA 077590
GALANTAMINE HYDROBROMIDE (GALANTAMINE HYDROBROMIDE)
EQ 4MG BASE
Marketing Status: Discontinued
EQ 8MG BASE
Marketing Status: Discontinued
EQ 12MG BASE
Marketing Status: Discontinued
EQ 4MG BASE
Marketing Status: Discontinued
Active Ingredient: GALANTAMINE HYDROBROMIDE
Proprietary Name: GALANTAMINE HYDROBROMIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 4MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A077590
Product Number: 001
Approval Date: May 29, 2009
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
GALANTAMINE HYDROBROMIDE (GALANTAMINE HYDROBROMIDE)
Proprietary Name: GALANTAMINE HYDROBROMIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 4MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A077590
Product Number: 001
Approval Date: May 29, 2009
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 8MG BASE
Marketing Status: Discontinued
Active Ingredient: GALANTAMINE HYDROBROMIDE
Proprietary Name: GALANTAMINE HYDROBROMIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 8MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A077590
Product Number: 002
Approval Date: May 29, 2009
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
GALANTAMINE HYDROBROMIDE (GALANTAMINE HYDROBROMIDE)
Proprietary Name: GALANTAMINE HYDROBROMIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 8MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A077590
Product Number: 002
Approval Date: May 29, 2009
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 12MG BASE
Marketing Status: Discontinued
Active Ingredient: GALANTAMINE HYDROBROMIDE
Proprietary Name: GALANTAMINE HYDROBROMIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 12MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A077590
Product Number: 003
Approval Date: May 29, 2009
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: GALANTAMINE HYDROBROMIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 12MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A077590
Product Number: 003
Approval Date: May 29, 2009
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information